AEON Biopharma, Inc. 10-Q filing
Filed 2026-05-14 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001837607-26-000042
- Form type
- 10-Q
- CIK
- 0001837607
- Primary document
- https://www.sec.gov/Archives/edgar/data/1837607/000183760726000042/aeon-20260331x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AEON Biopharma, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-5.9M | - | - |
| Net Income | $-11.8M | - | - |
| Eps Basic | -0.29 | - | - |
| Eps Diluted | -0.29 | - | - |
| Cash And Equivalents | $6.2M | - | - |
| Total Assets | $8.6M | - | - |
| Total Liabilities | $25.4M | - | - |
| Shareholders Equity | $-16.8M | - | - |
| Operating Cash Flow | $-2.6M | - | - |
| Capital Expenditures | $4,000 | - | - |